Jeffrey M. Dayno - 22 Jan 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
PRESIDENT, CEO, Director
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol
HRMY
Transactions as of
22 Jan 2026
Net transactions value
-$384,364
Form type
4
Filing time
26 Jan 2026, 16:43:34 UTC
Previous filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dayno Jeffrey M. PRESIDENT, CEO, Director C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING /s/ Christian Ulrich, Attorney-in-Fact 26 Jan 2026 0001615993

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRMY Common Stock Options Exercise $0 +10,500 $0.000000 10,500 24 Jan 2026 Direct
transaction HRMY Common Stock Tax liability $176,184 -4,785 -46% $36.82 5,715 24 Jan 2026 Direct F1
transaction HRMY Common Stock Options Exercise $0 +13,000 $0.000000 13,000 25 Jan 2026 Direct
transaction HRMY Common Stock Tax liability $208,180 -5,654 -43% $36.82 7,346 25 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Award $0 +184,600 $0.000000 184,600 22 Jan 2026 Common Stock 184,600 $36.76 Direct F2
transaction HRMY Restricted Stock Units Award $0 +52,900 $0.000000 52,900 22 Jan 2026 Common Stock 52,900 Direct F3
transaction HRMY Restricted Stock Units Options Exercise $0 -10,500 -33% $0.000000 21,000 24 Jan 2026 Common Stock 10,500 Direct F4
transaction HRMY Restricted Stock Units Options Exercise $0 -13,000 -25% $0.000000 39,000 25 Jan 2026 Common Stock 13,000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2 The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
F3 The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
F4 This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
F5 This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.